MP41-11 DEVIATIONS IN CYCLES OF NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER AND IMPLICATIONS FOR PATHOLOGIC RESPONSE AND SURVIVAL

INTRODUCTION AND OBJECTIVE:Ideal length of neoadjuvant chemotherapy (NAC) before cystectomy for muscle-invasive bladder cancer (MIBC) is uncertain. Trials initially studied 3 cycles, but 4 cycles a...